Medtronic PLC (MDT)

Industry Medical Devices
This stock can be held in an Investment ISA and an Investment Account
Sell

$84.29

Buy

$84.30

arrow-down$-0.82 (-0.96%)

Medtronic PLC is a medical technology company. It primarily manufacture and sell device-based medical therapies. It operates in Cardiac and Vascular, Minimally Invasive Therapies, Restorative Therapies and Diabetes segments.
Prices updated at 14 May 2025, 15:57 EDT
| Prices minimum 15 mins delay
|
Prices in USD
S&P 500
arrow-down-0.19%
NYSE
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
Our Investment Fees and Charges.
Sector
Healthcare
Industry
Medical Devices
Chairman
Mr. Geoffrey S. Martha
CEO
Mr. Geoffrey S. Martha
Most recent earnings
30 Apr 2024
Fiscal year end
30 Apr 2024
Employees
95,000
Head office
Lower Hatch Street
Dublin
Ireland
2
mobile
+353 14381700
letter
investor.relations@medtronic.com
computer
Company website

Key personnel

Owner nameSalaryBonusAll other compensationTotal compensationRestricted stock award
Ms. Denise M. O'Leary
Independent Director
0.20m--0.38m-
Mr. Gary Corona
Senior Vice President, Corporate Finance
-----
Mr. Thierry Pieton
Chief Financial Officer and Executive Vice President
-----
Mr. Denise L. Blomquist
Global Controller and Principal Accounting Officer
-----
Mr. Craig Arnold
Lead Independent Director
0.24m--0.41m-
Mr. Kendall J. Powell
Independent Director
0.18m--0.35m-
Ms. Lidia L. Fonseca
Independent Director
0.18m--0.35m-
Mr. Randall J. Hogan, III
Independent Director
0.21m--0.39m-
Mr. Ivan K. Fong
Executive Vice President, General Counsel and Corporate Secretary
-----
Mr. Scott C. Donnelly
Independent Director
0.19m--0.37m-
Mr. Gregory L. Smith
Executive Vice President, Global Operations and Supply Chain
0.87m--7.66m-
Mr. Kevin E. Lofton
Independent Director
0.20m--0.37m-
Mr. Brett A. Wall
Executive Vice President and President, Neuroscience Portfolio
0.75m--6.44m-
Mr. Geoffrey S. Martha
Chief Executive Officer and Chairman of the Board
1.35m--20.08m-
Dr. Elizabeth G. Nabel, M.D.
Independent Director
0.20m--0.37m-
Dr. Andrea J. Goldsmith, PhD
Independent Director
0.20m--0.37m-
Mr. Gregory P. Lewis
Independent Director
0.16m--0.31m-
Mr. Sean M. Salmon
Executive Vice President and President, Cardiovascular Portfolio
0.87m--6.55m-
Mr. Michael Marinaro
Executive Vice President and President, Medical Surgical Portfolio and Surgical Operating Unit
-----

Top 5 shareholders

Owner nameNo. of sharesShare as % of port.Last changePortfolio % changeDate of portfolio% Total assets
Vanguard Group Inc125,014,2410.20318108540.65284430 Apr 20259.74
BlackRock Inc114,172,8110.1845429147292.61979130 Apr 20258.90
State Street Corp60,437,4630.1921-293904-0.48394130 Apr 20254.71
Capital Research and Management Company46,353,88410.60112927558-30 Apr 20253.61
Vanguard Investments Australia Ltd41,348,0952.19208-1398090-30 Apr 20253.22

Director dealings

DateActionNamePriceValueNo. of sharesHolding (%)Additional info
16 Dec 2024-Mr. Ivan K. Fong82.4843,87954,692--
16 Dec 2024-Mr. Brett A. Wall82.4853,20043,708--
16 Dec 2024-Mr. Geoffrey S. Martha82.48364,314181,326--
16 Dec 2024-Mr. Sean M. Salmon82.4853,20064,722--
10 Dec 2024-Mr. Ivan K. Fong83.58251,49255,224--
06 Dec 2024-Ms. Jennifer M. Kirk84.0154,27028,011--
06 Dec 2024-Mr. Gary Corona84.0155,61532,721--
20 Aug 2024-Mr. Michael Marinaro85.38174,60240,346--
15 Aug 2024-Mr. Gary Corona--33,035--
02 Aug 2024-Mr. Ivan K. Fong-----
02 Aug 2024-Mr. Ivan K. Fong--61,029--
02 Aug 2024-Mr. Ivan K. Fong81.51279,00957,606--
02 Aug 2024-Mr. Ivan K. Fong--63,750--
02 Aug 2024-Mr. Ivan K. Fong81.51228,39160,948--
02 Aug 2024-Mr. Ivan K. Fong81.51243,30757,963--
02 Aug 2024-Mr. Ivan K. Fong-----
02 Aug 2024-Mr. Gregory L. Smith81.51111,99563,383--
02 Aug 2024-Mr. Gregory L. Smith--64,757--
02 Aug 2024-Mr. Gregory L. Smith-----
02 Aug 2024-Mr. Gregory L. Smith81.51123,32561,870--
Please note that past performance is not a reliable indicator of future returns.


Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.